Access Bio Inc Market Cap ($45.86 Million)
Market Cap & Net Worth: Access Bio Inc (950130)
Access Bio Inc market cap. Access Bio Inc (KQ:950130) has a market capitalization of $45.86 Million (₩67.67 Billion) as of November 1, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #22050 globally and #1363 in its home market, demonstrating a -1.84% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Access Bio Inc's stock price ₩1924.00 by its total outstanding shares 35173800 (35.17 Million). Also see how efficiently does Access Bio Inc generate cash for how efficiently the company converts equity into cash flow.
Access Bio Inc Market Cap History (2015–2026)
Access Bio Inc market cap history from 2015 to 2026. Data shows change from $172.10 Million to $45.86 Million (-13.40% CAGR). Check 950130 share price today for real-time trading data and today's change.
Access Bio Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Access Bio Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Access Bio Inc equity growth rate to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
1.50x
Access Bio Inc's market cap is 1.50 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $172.10 Million | $35.58 Billion | $1.26 Billion | 0.00x | 0.14x |
| 2016 | $145.88 Million | $27.99 Million | $262.09K | 5.21x | 556.61x |
| 2017 | $109.17 Million | $26.06 Million | -$5.74 Million | 4.19x | N/A |
| 2018 | $102.14 Million | $36.57 Million | -$3.85 Million | 2.79x | N/A |
| 2019 | $93.44 Million | $36.94 Million | -$15.09 Million | 2.53x | N/A |
| 2021 | $381.39 Million | $441.37 Million | $165.75 Million | 0.86x | 2.30x |
| 2022 | $290.81 Million | $800.23 Million | $268.33 Million | 0.36x | 1.08x |
| 2023 | $213.82 Million | $267.08 Million | -$2.43 Million | 0.80x | N/A |
| 2024 | $123.71 Million | $82.45 Million | -$254.83K | 1.50x | N/A |
Competitor Companies of 950130 by Market Capitalization
Companies near Access Bio Inc in the global market cap rankings as of November 1, 2026. Also see Access Bio Inc total assets for a full breakdown of the balance sheet.
Key companies related to Access Bio Inc by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #87 globally with a market cap of $224.59 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #143 globally with a market cap of $164.04 Billion USD.
- Natera Inc (NASDAQ:NTRA): Ranked #480 globally with a market cap of $56.33 Billion USD.
- WuXi AppTec Co Ltd (SHG:603259): Ranked #530 globally with a market cap of $51.40 Billion USD ( CN¥351.23 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #87 | Thermo Fisher Scientific Inc | NYSE:TMO | $224.59 Billion | $697.00 |
| #143 | Danaher Corporation | NYSE:DHR | $164.04 Billion | $232.23 |
| #480 | Natera Inc | NASDAQ:NTRA | $56.33 Billion | $414.30 |
| #530 | WuXi AppTec Co Ltd | SHG:603259 | $51.40 Billion | CN¥142.01 |
Market Capitalization of Access Bio Inc (2015–2026)
Market capitalization of Access Bio Inc from 2015 to today. Between 2015 and today, Access Bio Inc's market cap moved from $172.10 Million to $ 45.86 Million, with a yearly change of -13.40%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩45.86 Million | -63.42% |
| 2025 | ₩125.38 Million | +1.35% |
| 2024 | ₩123.71 Million | -42.14% |
| 2023 | ₩213.82 Million | -26.48% |
| 2022 | ₩290.81 Million | -23.75% |
| 2021 | ₩381.39 Million | +308.16% |
| 2019 | ₩93.44 Million | -8.52% |
| 2018 | ₩102.14 Million | -6.44% |
| 2017 | ₩109.17 Million | -25.16% |
| 2016 | ₩145.88 Million | -15.24% |
| 2015 | ₩172.10 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Access Bio Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $45.86 Million USD |
| MoneyControl | $45.86 Million USD |
| MarketWatch | $45.86 Million USD |
| marketcap.company | $45.86 Million USD |
| Reuters | $45.86 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Access Bio Inc
Access Bio, Inc. engages in the research, development, and manufacture of in vitro rapid diagnostic tests, biosensors, and molecular diagnostic products worldwide. The company provides Covid-19 detection kits, which are tests for assessing the current or past presence of SARS-CoV-2.; rapid diagnostic tests, suitable for preliminary diagnosis or emergency medical screening in medical facilities wi… Read more